betamethasone dipropionate + betamethasone sodium phosphate + prilocaine

This appears to be a combination medication that includes two forms of betamethasone (a corticosteroid) and prilocaine (a local anesthetic). The provided text indicates that this exact three-component combination is **not explicitly mentioned** in the search results as an existing marketed product and suggests it may be a compounded medication prepared by pharmacists for specific patient needs rather than a commercially available product. Individual Components: * **Betamethasone dipropionate:** A synthetic corticosteroid available in various topical formulations (cream, ointment, lotion, gel, spray). It is used to treat inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses and is classified as a super potent (class I) corticosteroid in gel or ointment form. * **Betamethasone sodium phosphate:** An injectable form of betamethasone used for various inflammatory conditions including acute graft-versus-host disease, nonsuppurative thyroiditis, and nephrotic syndrome. * **Prilocaine:** A local anesthetic often used for numbing during medical procedures, sometimes found in combination products like EMLA (with lidocaine) for topical application. Without specific information about this exact three-component combination product, details about its specific indications, dosing, or typical formulation (e.g., topical, injectable) cannot be provided, though the components themselves suggest potential uses for inflammation and pain/numbing.